Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
RubrYc Therapeutics is a biotechnology company.
Edifice Health is a immunological health and personalized nutrition company offering a novel metric of inflammatory health.
Cofense provides phishing threat management and remediation solutions to the world's leading brands and organizations.
Change Donations is a micro-donation platform helping charities fundraise more efficiently and connect with a younger generation
10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.
Teraki is a driver for scaling of insurance, maintenance and autonomous driving applications by enabling access to more qualitative data.
RiskLens empowers risk officers and CISOs to manage their cyber risk from a business perspective by quantifying it in financial terms
Anomali delivers the leading AI-Powered Security and IT Operations Platform.
Paladin Capital Group has invested in 80 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Paladin Capital Group's top investment sectors include Biotechnology, Health Care, Cyber Security, Security, Medical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Anomali received $40.0M in a Series D round. Paladin Capital Group's total known invested capital is $1.5B.
Paladin Capital Group's average investment size is $22.4M across its portfolio of 80 companies.
Recent Paladin Capital Group portfolio additions include RubrYc Therapeutics, Edifice Health, Cofense, Change Donations. These companies were founded in 2020 or later.